UK
UK
Aug-17
Nephrology Pharmacoepidemiology
Read moreAug-17
Mental Health Neurology Pharmacoepidemiology
Read moreAug-17
Other Vascular Pharmacoepidemiology
Read moreAug-17
Endocrinology Geriatrics Pharmacoepidemiology
Read moreAug-17
Geriatrics Mental Health Neurology Pharmacoepidemiology
Read moreAug-17
Mental Health Pharmacoepidemiology
Read moreAug-17
Cardiovascular Endocrinology Pharmacoepidemiology
Read moreAug-17
Cardiovascular Pharmacoepidemiology
Read moreJul-17
Cardiovascular Endocrinology Pharmacoepidemiology
Read moreJul-17
Cardiovascular Pharmacoepidemiology
Read moreJul-17
Endocrinology Pharmacoepidemiology
Read more| Date | Title | Categories | |
|---|---|---|---|
| Aug-17 | Understanding the epidemiology of chronic lithium use leading to renal failure. The first large scale study of 26,414 incident patients starting lithium, using data from the health improvement network (THIN) in UK primary care | Read more | |
| Aug-17 | Antipsychotic Utilization Patterns in a Cohort of 1.5 Million Schizophrenic Patients. A Cross‐National Study | Read more | |
| Aug-17 | Impact of Risk Minimization Measures on the Use of Cilostazol in Europe | Read more | |
| Aug-17 | Comparative Effectiveness of Sitagliptin Compared to Sulphonylureas for Type 2 Diabetes Among Elderly Patients Inadequately Controlled on Metformin | Read more | |
| Aug-17 | Clinical Indications for Fluoroquinolones in Routine Care | Read more | |
| Aug-17 | Assessment of the Effect of Minimization Measures of the Risk of Stroke with Antipsychotic Use in Elderly Persons: A Nested Case‐Control Study | Read more | |
| Aug-17 | Movement side effects of antipsychotic drugs in adults with and without intellectual disability: UK population-based cohort study | Read more | |
| Aug-17 | Effects of background statin therapy on glycemic response and cardiovascular events following initiation of insulin therapy in type 2 diabetes: a large UK cohort study | Read more | |
| Aug-17 | Comparative Cardiovascular Safety of Strontium Ranelate and Bisphosphonates Amongst Patients with No Contraindications: a Multidatabase Study in our European Countries by the EU-ADR Alliance | Read more | |
| Jul-17 | The effects of dual-therapy intensification with insulin or dipeptidylpeptidase-4 inhibitor on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A retrospective cohort study | Read more | |
| Jul-17 | Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors) | Read more | |
| Jul-17 | Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes | Read more |
